FSGEX
Price
$20.81
Change
+$0.01 (+0.05%)
Updated
Jul 31 closing price
Net Assets
74.78B
IHOAX
Price
$23.90
Change
+$0.04 (+0.17%)
Updated
Jul 31 closing price
Net Assets
4.04B
Interact to see
Advertisement

FSGEX vs IHOAX

FSGEX vs IHOAX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. IHOAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Hold and IHOAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.8B vs. IHOAX (4.04B). FSGEX pays higher dividends than IHOAX: FSGEX (2.66) vs IHOAX (1.26). FSGEX was incepted earlier than IHOAX: FSGEX (17 years) vs IHOAX (30 years). IHOAX (1.08) is less costly to investors than FSGEX (0.01). IHOAX is a more actively managed with annual turnover of: 46.00 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than IHOAX: FSGEX (0) vs IHOAX (2000). FSGEX annual gain was more profitable for investors over the last year : 28.80 vs. IHOAX (15.86). FSGEX return over 5 years is better than : 55.46 vs. IHOAX (22.77).
FSGEXIHOAXFSGEX / IHOAX
Total Expense Ratio0.011.081%
Annual Report Gross Expense Ratio0.011.081%
Fund Existence17 years30 years-
Gain YTD13.7169.633142%
Front LoadN/A6%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets74.8B4.04B1,851%
Annual Yield % from dividends2.661.26211%
Returns for 1 year28.8015.86182%
Returns for 3 years63.2246.53136%
Returns for 5 years55.4622.77244%
Returns for 10 years135.0584.39160%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX20.370.29
+1.44%
NYLI PineStone U.S. Equity Class C
MAILX24.190.17
+0.71%
BlackRock International Instl
MMMMX56.82-0.14
-0.25%
Victory Integrity Discovery Member
PDGIX89.88-0.39
-0.43%
T. Rowe Price Dividend Growth I
MGHRX63.84-1.31
-2.01%
Morgan Stanley Inst Growth IR